Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide

INTRODUCTION: Nearly 80% of advanced prostate cancer patients respond to initial androgen deprivation therapy (ADT). However, ADT does not prevent the progression of prostate cancer over the long term, and the disease eventually progresses to castration-resistant prostate cancer (CRPC). Prior to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumano, Yohei, Hasegawa, Yoriko, Kawahara, Takashi, Yasui, Masato, Miyoshi, Yasuhide, Matsubara, Nobuaki, Uemura, Hiroji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360569/
https://www.ncbi.nlm.nih.gov/pubmed/30800682
http://dx.doi.org/10.1155/2019/9450838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360569/
https://www.ncbi.nlm.nih.gov/pubmed/30800682
http://dx.doi.org/10.1155/2019/9450838

Ejemplares similares